Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?

Frontiers in Medicine
Shi Huan TayThaschawee Arkachaisri

Abstract

Juvenile spondyloarthritis (JSpA) refers to a diverse spectrum of immune-mediated inflammatory arthritides whose onset occurs in late childhood and adolescence. Like its adult counterpart, JSpA is typified by a strong association with human leukocyte antigen-B27 (HLA-B27) and potential axial involvement, while lacking rheumatoid factor (RF) and distinguishing autoantibodies. A characteristic manifestation of JSpA is enthesitis (inflammation of insertion sites of tendons, ligaments, joint capsules or fascia to bone), which is commonly accompanied by bone resorption and new bone formation at affected sites. In this Review, advances in the role of HLA-B27, enthesitis and its associated osteoproliferation in JSpA pathophysiology and treatment options will be discussed. A deeper appreciation of how these elements contribute to the JSpA disease mechanism will better inform diagnosis, prognosis and therapy, which in turn translates to an improved quality of life for patients.

References

Apr 1, 1990·Immunology Today·R Benjamin, P Parham
Apr 1, 1987·Annals of the Rheumatic Diseases·B Andersson GäreA Thilen
Sep 1, 1996·Annals of the Rheumatic Diseases·O Kaipiainen-SeppänenM Laakso
Jul 31, 2001·The Journal of the American Academy of Orthopaedic Surgeons·T A Belanger, D E Rowe
Nov 13, 2002·Arthritis and Rheumatism·Simon KollnbergerPaul Bowness
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ekkehard MayJoel D Taurog
Mar 6, 2004·Science·Nathalie VigneronBenoît J Van den Eynde
Nov 7, 2006·Prostaglandins & Other Lipid Mediators·Cynthia B Alander, Lawrence G Raisz
Jan 24, 2007·Nature Medicine·Danielle DiarraGeorg Schett
Feb 1, 2007·Arthritis and Rheumatism·Rik J U LoriesFrank P Luyten
May 29, 2007·Arthritis and Rheumatism·R K SaurenmannE D Silverman
Sep 3, 2008·Arthritis Research & Therapy·Xenofon BaraliakosJuergen Braun
Sep 30, 2008·Arthritis and Rheumatism·Désirée van der HeijdeUNKNOWN Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
Mar 24, 2009·Annals of the Rheumatic Diseases·S UderhardtG Schett
Apr 7, 2009·Bone·Kim HenriksenMorten A Karsdal
May 15, 2009·Arthritis Research & Therapy·Rik J U LoriesKurt de Vlam
Jul 1, 2009·Arthritis and Rheumatism·Joel D TaurogHolger M Reichardt
Aug 26, 2009·Arthritis Research & Therapy·Désirée van der HeijdeUNKNOWN ATLAS study group
Oct 31, 2009·Arthritis and Rheumatism·David A CabralUNKNOWN ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network
Dec 17, 2009·Nature Reviews. Immunology·Marcus GroettrupMichael Basler
Feb 20, 2010·Arthritis Research & Therapy·Iannis E AdamopoulosEdward P Bowman
Sep 23, 2010·Scandinavian Journal of Rheumatology·C ModestoP Barceló
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jane C GoodallJ S Hill Gaston
Jan 21, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul BownessSimon Kollnberger
Jun 8, 2011·Current Osteoporosis Reports·Shea Carter, Rik J Lories
Jul 12, 2011·Nature Genetics·David M EvansUNKNOWN Wellcome Trust Case Control Consortium 2 (WTCCC2)
Dec 14, 2011·Journal of Anatomy·C M WaughT Korff
Apr 11, 2012·Nature Reviews. Rheumatology·Shirley M L Tse, Ronald M Laxer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Current Opinion in Rheumatology
Sabrina Gmuca, Pamela F Weiss
Pediatric Rheumatology Online Journal
María Martha Katsicas, Ricardo Russo
Current Rheumatology Reports
Hemalatha SrinivasaluChristopher Redmond
© 2021 Meta ULC. All rights reserved